Product Categories
| Country: | United States |
|---|---|
| Tel: | +1-781-999-5354 |
| Mobile: | +1-00000000000 |
| E-mail: | marketing@targetmol.com |
| QQ: | |
| Skype: | Chat Now! |
| Address: | 36?Washington?Street, Wellesley?Hills |
|
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
|
|
| Product Name | MF | CAS | Details |
|---|
| NED-3238 | C17H28BN3O4 | 2389062-09-1 | Details |
| Dianemycin | C47H78O14 | 35865-33-9 | Details |
| NCI172112；NSC268497;NSC172112 | C14H23Cl2N3O2 | 56605-16-4 | Details |
| NCGC00249987 | C16H11FN4O2S | 1384864-80-5 | Details |
| NCGC00247743 | C24H29N3O2 | 1435192-04-3 | Details |
| NBTGR | C17H18N6O6S | 13153-27-0 | Details |
| Trans (2,3)-Dihydrotetrabenazine；(2R,3R,11bR)-rel-Dihydrotetrabenazine;(2R,3R,11bR)-rel-DHTBZ | C19H29NO3 | 171598-74-6 | Details |
| Naspm；1-Naphthylacetyl spermine | C22H34N4O | 122306-11-0 | Details |
| Naveglitazar racemate | C25H26O6 | 916085-47-7 | Details |
| Nav1.7 inhibitor | C15H11Cl3FNO4S | 1355631-24-1 | Details |
| Nav1.7-IN-3 | C17H20ClFN4O2S2 | 1788872-06-9 | Details |
| Nav1.7-IN-2 | C22H22FN5O2 | 1332295-35-8 | Details |
| Nav1.7-IN-6 | C25H25ClF6N2O4S | 1788066-71-6 | Details |
| Nav1.1 activator 1 | C24H23F3N4O | 2332897-85-3 | Details |
| Nateglinide D5；Senaglinide D5;A4166 D5 | C19H22D5NO3 | 1227666-13-8 | Details |
| Natalizumab | C40H55N7O11S | 189261-10-7 | Details |
| Naratriptan D3 Hydrochloride；GR-85548A D3 | C17H25ClN3O2S | 1190021-64-7 | Details |
| Naquotinib mesylate；ASP8273 (mesylate) | C31H46N8O6S | 1448237-05-5 | Details |
| NAN-190 hydrobromide | C23H28BrN3O3 | 115338-32-4 | Details |
| NCGC00229600 | C30H29N3O3 | 1338824-20-6 | Details |
| Sisomicin Sulfate | C19H39N5O11S | 53179-09-2 | Details |
| NaV1.7 inhibitor-1 | C23H30FNO4S | 1494585-79-3 | Details |
| Cefoperazone sodium salt | C25H28N9NaO8S2 | 62893-20-3 | Details |
| Naphthoquine phosphate | C24H31ClN3O5P | 173531-58-3 | Details |
| NBDHEX | C12H15N3O4S | 787634-60-0 | Details |
| NB-360 | C21H19F4N5O2 | 1262857-73-7 | Details |
| Naspm trihydrochloride | C22H35ClN4O | 1049731-36-3 | Details |
| NCX899 | C23H33N3O8 | 690655-41-5 | Details |
| NB-598 hydrochloride | C27H32ClNOS2 | 136719-25-0 | Details |
| Ethidium bromide；EtBr;Homidium bromide;EB | C21H20BrN3 | 1239-45-8 | Details |
| Nec-4 | C15H13ClFN3O | 1041644-43-2 | Details |
| Nebracetam hydrochloride | C12H17ClN2O | 1177279-49-0 | Details |
| NCT-506 | C25H23FN4O3S | 2231098-99-8 | Details |
| NCT-505 | C27H28FN5O3S | 2231079-74-4 | Details |
| Necrostatin 2 S enantiomer | C13H12ClN3O2 | 852391-20-9 | Details |
| Necrostatin 2 | C13H12ClN3O2 | 852391-19-6 | Details |
| Ned 19 | C30H31FN4O3 | 874374-25-1 | Details |
| NecroX-5 | C26H35N3O6S2 | 1383718-29-3 | Details |
| Navitoclax-piperazine | C47H56ClF3N6O5S3 | 2143096-93-7 | Details |
| NB-598 Maleate | C31H35NO5S2 | 155294-62-5 | Details |
| Nepafenac-d5；AHR-9434 D5;Nepafenac D5;AL-6515 D5 | C15H14N2O2 | 1246814-53-8 | Details |
| Netropsin dihydrochloride | C18H27ClN10O3 | 18133-22-7 | Details |
| NEO 376 | C20H24ClN3O | 496921-73-4 | Details |
| Netupitant metabolite Monohydroxy Netupitant；Monohydroxy Netupitant | C30H32F6N4O2 | 910808-12-7 | Details |
| Netupitant metabolite N-desmethyl Netupitant；N-desmethyl Netupitant | C29H30F6N4O | 290296-72-9 | Details |
| Acetylcholine chloride | C7H16ClNO2 | 60-31-1 | Details |
| NF-56-EJ40 | C27H29N3O3 | 2380230-73-7 | Details |
| Nexopamil racemate | C24H40N2O3 | 116759-35-4 | Details |
| Neurotoxin Inhibitor | C19H14N4OS | 951571-70-3 | Details |
| Netupitant metabolite Netupitant N-oxide；Netupitant N-oxide | C30H32F6N4O2 | 910808-11-6 | Details |
| NF546 | C47H44N6Na4O17P4 | 1006028-37-0 | Details |
| NPS ALX Compound 4a dihydrochloride | C25H26ClN3O2S | 1781934-44-8 | Details |
| NPS ALX Compound 4a | C25H25N3O2S | 299433-10-6 | Details |
| NIC3 | C26H36N2O4 | 494830-67-0 | Details |
| NFAT Transcription Factor Regulator-1 | C17H10F6N4O2 | 245747-71-1 | Details |
| NHE3-IN-1 | C12H10ClN3S | 632355-68-1 | Details |
| Nicardipine-d3 hydrochloride；Nicardipine D3 hydrochloride;YC-93 D3 | C26H26D3N3O6 | 1432061-50-1 | Details |
| Nifedipine-d6；Nifedipine D6;BAY-a-1040 D6 | C17H12D6N2O6 | 1188266-14-9 | Details |
| Nilotinib-d6；AMN107 D6;Nilotinib D6 | C28H16D6F3N7O | 1268356-17-7 | Details |
| Trifluoperazine dihydrochloride | C21H26Cl2F3N3S | 440-17-5 | Details |
| Nifursemizone | C8H10N4O4 | 5579-89-5 | Details |
| Niraparib metabolite M1；Niraparib carboxylic acid metabolite M1;M1 metabolite of niraparib | C19H19N3O2 | 1476777-06-6 | Details |
| NIM811；SDZ NIM811;(Melle-4)cyclosporin | C62H111N11O12 | 143205-42-9 | Details |
| Nevanimibe hydrochloride | C27H40ClN3O | 133825-81-7 | Details |
| NITD-349 | C17H20F2N2O | 1473450-62-2 | Details |
| NMDI14 | C21H25N3O4S | 307519-88-6 | Details |
| NMS-859 | C15H12ClN3O3S | 1449236-96-7 | Details |
| NMS-P715 | C35H39F3N8O3 | 1202055-32-0 | Details |
| Cefuroxime sodium | C16H15N4O8S.Na | 56238-63-2 | Details |
| Norbinaltorphimine dihydrochloride | C40H44ClN3O6 | 113158-34-2 | Details |
| NOT Receptor Modulator 1；2-(3-(2-(4-chlorophenyl)imidazo[1,2-a]pyridin-6-yl)phenyl)propan-2-ol | C22H19ClN2O | 1015231-98-7 | Details |
| NR1H4 activator 1 | C34H53NO7S | 2242855-68-9 | Details |
| NRA-0160 | C24H23F2N3OS | 204718-47-8 | Details |
| NSC 601980 (analog) | C15H14N4 | 91757-46-9 | Details |
| Nourseothricin sulfate | C44H82N18O21S | 96736-11-7 | Details |
| NSC117079 | C20H15N3O7S2 | 500363-63-3 | Details |
| NSC232003 | C6H7N3O3 | 1905453-18-0 | Details |
| Bacitracin | C66H102N17O16S | 1405-87-4 | Details |
| Nitazoxanide-d4；NSC-697855 D4;Nitazoxanide D4;NTZ D4 | C12H9N3O5S | 1246819-17-9 | Details |
| NK-1 Antagonist 1；Rolapitant intermediate | C25H23F6N5O2 | 873947-10-5 | Details |
| NNC45-0781 | C27H29NO3 | 207277-66-5 | Details |
| nor-NOHA acetate；Nω-Hydroxy-nor-L-arginine acetate | C5H12N4O3 ? 2C2H4O2 | 1140844-63-8 | Details |
| Nitroxazepine | C18H19N3O4 | 47439-36-1 | Details |
| Ceftriaxone sodium hydrate | C18H21N8NaO8S3 | 104376-79-6 | Details |
| NNC 55-0396 | C30H39ClFN3O2 | 357400-13-6 | Details |
| NMDA-IN-1 | C20H23ClFN3O | 700878-19-9 | Details |
| Nosantine racemate；NPT-15392 racemate | C14H22N4O2 | 75166-67-5 | Details |
| Norverapamil；(±)-Norverapamil;D591 | C26H36N2O4 | 67018-85-3 | Details |
| Norverapamil-d7；D591 D7;(±)-Norverapamil D7;Norverapamil D7 | C26H29D7N2O4 | 263175-44-6 | Details |
| Norvancomycin hydrochloride；Desmethyl-vancomycin hydrochloride | C65H74Cl3N9O24 | 213997-73-0 | Details |
| CB-103 | C15H18N2O | 218457-67-1 | Details |
| NS-3-008 hydrochloride | C14H24ClN3 | 1172854-54-4 | Details |
| NSC 146109 hydrochloride | C17H17ClN2S | 59474-01-0 | Details |
| NS8593 hydrochloride | C17H17N3.ClH | 875755-24-1 | Details |
| NS19504 | C10H9BrN2S | 327062-46-4 | Details |
| Nrf2-IN-1 | C21H22ClN3O2 | 1610022-76-8 | Details |
| NPB | C29H31Cl2N3O2 | 2247491-97-8 | Details |
| Nevanimibe；ATR-101;PD-132301 | C27H39N3O | 133825-80-6 | Details |
| Niperotidine | C20H26N4O5S | 84845-75-0 | Details |
| Nimesulide D5 | C13H7D5N2O5S | 1330180-22-7 | Details |
| Product Total： Product Page： | ||||
| 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 | ||||